Advertisement

Related Videos

Varsha Gandhi, PhD, on Ibrutinib

Peter Clark, MA, MD, FRCP: A Payer Perspective

Opening Session Panel Discussion

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Advertisement

Advertisement




Jan
26
Today In Oncology
Pembrolizumab Plus Lenvatinib in Recurrent Gynecologic Clear Cell Carcinoma
Leader in Global Cancer Care, Paul E. Goss, MD, PhD, Dies at 70
Nutrition Muscle Loss Compromises Survival in Patients With Cervical Cancer Undergoing Chemoradiotherapy
New Report Shows Colorectal Cancer is Now Leading Cancer Death Among Those Under 50
Prostate Cancer: Novel PSMA-Targeted Radioligand Shows Reduced Salivary Gland Uptake in Preclinical Studies
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo